2008 Portfolio News
News from the portfolios of HBM BioVentures and HBM BioCapital
Biomarin's Kuvan receives marketing approval in the EU (21 KB)09.12.2008
- Broncus Technologies Secures 38$ Million in fundind round led by Ares Life Sciences (14 KB)
04.12.2008
- Sale of private portfolio company Panomics (36 KB)
12.11.2008
- Biovitrum extends ReFacto supply agreement with Wyeth until Dec. 31, 2015 (71 KB)
12.11.2008
- Brahms announces new blood test better predicts heart failure outcomes in emergency setting (50 KB)
11.11.2008
- Paratek reports positive phase 2 clinical data on antibiotic PTK 0796 (77 KB)
26.10.2008
- Mpex Pharmaceuticals presents new data on MP-376 in Cystic Fibrosis (34 KB)
23.10.2008
- Probiodrug's new Alzheimer's treatment paradigm published in Nature Medicine (65 KB)
28.09.2008
- Takeover of public portfolio company CryoCath Technologies (40 KB)
26.09.2008
- Biovitrum to acquire Kepivance, Stemgen and exclusively license (90 KB)
15.09.2008
- Basilea's Toctino (alitretinoin) receives first national marketing authorization in the UK (30 KB)
08.09.2008
- BRAHMS AG: Substantial success in the improvement of diagnosis of patients suffering from shortness of breath (65 KB)
01.09.2008
News
M&A Report
Links
Subscribe To Our Newsletter
Search
© HBM Partners AG 18.05.2012